Acute myeloid leukemia in the next-generation sequencing era
Our study validates data from CCIT and supports their relevance for treatment decisions in a real-world setting. Moreover, they demonstrate the feasibility and benefits of NGS within a routine clinical setting.
Authors
- Sonja Wurm (ORCID: https://orcid.org/0000-0002-7540-737X)
- Sereina A. Herzog (ORCID: https://orcid.org/0000-0002-5373-5866)
- Andrea Berghold (ORCID: https://orcid.org/0000-0001-5187-9105)
- Gerhard Bachmaier (ORCID: https://orcid.org/0000-0002-8291-7255)
- Hildegard Greinix (ORCID: https://orcid.org/0000-0002-2780-3300)
- Jennifer Moritz (ORCID: https://orcid.org/0000-0001-5574-6692)
- Andreas Reinisch (ORCID: https://orcid.org/0000-0001-9333-7689)
- Karl Kashofer (ORCID: https://orcid.org/0000-0002-5803-4014)
- Armin Zebisch (ORCID: https://orcid.org/0000-0002-4861-7021)
- Albert Wölfler (ORCID: https://orcid.org/0000-0002-3112-9857)
- Heinz Sill (ORCID: https://orcid.org/0000-0003-0993-4371)
- Gerald Höefler (ORCID: https://orcid.org/0000-0002-9056-3063)
- Christine Beham‐Schmid
- Michael Waltersdorfer
- Simone Loindl
Institutions
- Medical University of Graz (AT)
Publication Details
- Journal
- Wiener klinische Wochenschrift
- Published
- 2024-11-11
- DOI
- https://doi.org/10.1007/s00508-024-02463-w
- Citations
- 3
- Primary Topic
- Acute Myeloid Leukemia Research
- Type
- article
- Field-Weighted Citation Impact
- 1.36
Funders
- Austrian Science Fund
- Österreichische Gesellschaft für Hämatologie und Onkologie
- Medizinische Universität Graz